Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer

NCT02799706 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

885

Enrollment

NETWORK

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Degarelix
DRUG: approved GnRH agonist
RADIATION: Radiotherapy

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC